Stay updated on Pembrolizumab and CC-486 in Platinum-resistant Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and CC-486 in Platinum-resistant Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and CC-486 in Platinum-resistant Ovarian Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-06T22:37:21.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error page with a minimal header and a Home button. This indicates access restrictions rather than changes to the study content.
    Difference
    0.5%
    Check dated 2026-09-29T22:33:46.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error for the study record, replacing the usual content with a standard error screen and a Home button. This indicates the page content is temporarily unavailable due to access restrictions.
    Difference
    20%
    Check dated 2026-09-23T00:22:47.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.6 to v3.7.0, indicating a deployment of a newer version of the page or site template. This change appears to be a metadata update rather than a modification to the study content.
    Difference
    0.1%
    Check dated 2026-09-15T23:42:33.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.6, replacing the previous Revision: v3.6.5, indicating a minor site/build update.
    Difference
    0.1%
    Check dated 2026-09-01T19:12:30.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing the prior Revision: v3.6.4, indicating a small software update rather than any changes to the study details.
    Difference
    0.0%
    Check dated 2026-08-11T06:19:16.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and CC-486 in Platinum-resistant Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and CC-486 in Platinum-resistant Ovarian Cancer Clinical Trial page.